Abstract
ObjectivePrimary orbital lymphoma (POL) accounts for an essential part of adult orbital malignancies. Nevertheless, it remains a relatively rare lymphoid malignancy, accounting for <1% of all non-Hodgkin's lymphoma (NHL) cases. Orbital diffuse large B-cell lymphoma (DLBCL) is one of the most prevalent subtypes of POL that confers the worst outcomes. The prognostic determinants of orbital DLBCL remain unknown. Therefore, a retrospective analysis was conducted by investigating the Surveillance, Epidemiology, and End Results (SEER) database for independent predictive factors for the prognosis of orbital DLBCL.Materials and methodsUsing the SEER program, we acquired patient data including demographics, clinical characteristics, and treatment strategies. Our cohort included cases of primary orbital DLBCL diagnosed from 2000 to 2017. We conducted Kaplan-Meier analyses to visualize the overall survival (OS) and cause-specific survival (CSS). The Cox proportional hazard regression models were applied to assess the effects of these prognostic factors on OS and CSS.ResultsThe present cohort included 332 patients with orbital DLBCL. Age was the most impacted variable by orbital DLBCL. Three independent prognostic variables of orbital DLBCL were identified on diagnosis: advanced age, no radiation treatment, and late-stage (Stage IV). Moreover, patients who underwent chemotherapy demonstrated a greater OS when compared with those who did not. In orbital DLBCL, being unmarried was also a poor prognostic factor.ConclusionThe current study is the largest population-based case series of orbital DLBCL. The age at the time of diagnosis, marital status, absence of chemotherapy or radiotherapy, and tumor stage were all found to be correlated with worse prognosis.
Full Text
Topics from this Paper
Primary Diffuse Large B-cell Lymphoma
non-Hodgkin's Lymphoma
Surveillance, Epidemiology, And End Results
Diffuse Large B-cell Lymphoma
Cox Proportional Hazard Regression Models
+ Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Blood
Nov 16, 2012
Blood
Nov 13, 2019
Medicine
Oct 8, 2021
Blood
Nov 16, 2007
Blood
Dec 6, 2014
Annals of Hematology
Jun 21, 2019
Menoufia Medical Journal
Oct 1, 2016
Hematological Oncology
Jun 1, 2015
Chinese Journal of Pathology
May 8, 2019
Virchows Archiv
Dec 4, 2013
Recent patents on anti-cancer drug discovery
Aug 1, 2024
Frontiers in Medicine
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 27, 2023
Frontiers in Medicine
Nov 24, 2023
Frontiers in Medicine
Nov 24, 2023